# Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

> **NCT03308721** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 99 (actual)

## Conditions studied

- Metabolism and Nutrition Disorder
- Obesity

## Interventions

- **DRUG:** NNC9204-1177 A 1.0 mg/mL
- **DRUG:** PLACEBO

## Key facts

- **NCT ID:** NCT03308721
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-16
- **Primary completion:** 2020-01-03
- **Final completion:** 2020-01-03
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2021-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03308721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03308721, "Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03308721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*